Cyclohexylamine

ID: ALA1794762

Cas Number: 108-91-8

PubChem CID: 7965

Product Number: C105035, Order Now?

Max Phase: Preclinical

Molecular Formula: C6H13N

Molecular Weight: 99.18

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  NC1CCCCC1

Standard InChI:  InChI=1S/C6H13N/c7-6-4-2-1-3-5-6/h6H,1-5,7H2

Standard InChI Key:  PAFZNILMFXTMIY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.0331    0.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7476    0.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7476   -0.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0331   -1.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6813   -0.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6813    0.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0331    1.4143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
M  END

Alternative Forms

  1. Parent:

    ALA1794762

    Cyclohexylamine
  2. Alternative Forms:

Associated Targets(Human)

SLC22A1 Tchem Solute carrier family 22 member 1 (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 99.18Molecular Weight (Monoisotopic): 99.1048AlogP: 1.28#Rotatable Bonds:
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.45CX LogP: 1.17CX LogD: -1.57
Aromatic Rings: Heavy Atoms: 7QED Weighted: 0.49Np Likeness Score: 0.01

References

1. Bednarczyk D, Ekins S, Wikel JH, Wright SH..  (2003)  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.,  63  (1): [PMID:12606755] [10.1124/mol.63.3.489]
2. PubChem BioAssay data set, 
3. PubChem BioAssay data set, 
4. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]